These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 20487441)
1. A commentary on variant Creutzfeld-Jacob disease. Hoots K Haemophilia; 2010 Mar; 16(2):238-9. PubMed ID: 20487441 [No Abstract] [Full Text] [Related]
2. Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products. Prowse C; Cuthbertson B; Turner M Haemophilia; 2011 Jul; 17(4):703. PubMed ID: 21362112 [No Abstract] [Full Text] [Related]
3. Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: implications for physicians. MacKnight C; Rockwood K CMAJ; 1996 Sep; 155(5):529-36. PubMed ID: 8804258 [TBL] [Abstract][Full Text] [Related]
4. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Turner ML; Ludlam CA Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452 [TBL] [Abstract][Full Text] [Related]
5. [Aspects of the risks associated with vCJK from plasma derivatives from human plasma]. Burger R; Offergeld R Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jun; 52(6):648-9. PubMed ID: 19557456 [No Abstract] [Full Text] [Related]
6. vCJD and blood transfusion in the United Kingdom. Hewitt P Transfus Clin Biol; 2006 Nov; 13(5):312-6. PubMed ID: 17188541 [TBL] [Abstract][Full Text] [Related]
8. New variant Creutzfeldt-Jakob disease and the blood supply: is it time to face the music? Hoey J; Giulivi A; Todkill AM CMAJ; 1998 Sep; 159(6):669-70. PubMed ID: 9780967 [No Abstract] [Full Text] [Related]
9. Creutzfeld-Jakob disease: the Grace General Hospital experience. Pauls F; Hayes J; Read J Leadersh Health Serv; 1996; 5(6):42-3. PubMed ID: 10163983 [TBL] [Abstract][Full Text] [Related]
10. The impact of variant CJD on transfusion practices in the UK. Boulton F Transfus Apher Sci; 2003 Apr; 28(2):107-16. PubMed ID: 12679113 [TBL] [Abstract][Full Text] [Related]
11. Creutzfeldt-Jakob disease and the risk from blood or blood products. Will RG; Kimberlin RH Vox Sang; 1998; 75(3):178-80. PubMed ID: 9852403 [TBL] [Abstract][Full Text] [Related]
13. Variant Creutzfeldt-Jakob disease and the Quebec blood supply. Germain M; Décary F; Chiavetta J; Goldman M CMAJ; 2000 Aug; 163(4):412-3. PubMed ID: 10976257 [No Abstract] [Full Text] [Related]
14. [Variants of Creutzfeldt Jacob disease. Opinion of the Working Group on Blood of the Federal Ministry for Health and Social Security]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):1082-90. PubMed ID: 16160898 [No Abstract] [Full Text] [Related]
16. Variant Creutzfeldt-Jakob disease and prions in the blood supply. Rohwer RG; Drohan W Clin Adv Hematol Oncol; 2004 Feb; 2(2):84, 87, 131. PubMed ID: 16163166 [No Abstract] [Full Text] [Related]
17. Under pressure. Siddall R Health Serv J; 2003 Aug; 113(5869):12-3. PubMed ID: 12953390 [No Abstract] [Full Text] [Related]
18. Variant Creutzfeldt-Jacob disease - the availability of a screening test will be the beginning, not the end, of difficult transfusion-related issues. Sandler SG Curr Opin Hematol; 2006 Nov; 13(6):445-6. PubMed ID: 17053456 [No Abstract] [Full Text] [Related]
19. Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases. Puopolo M; Ladogana A; Vetrugno V; Pocchiari M Transfusion; 2011 Jul; 51(7):1556-66. PubMed ID: 21214582 [TBL] [Abstract][Full Text] [Related]